Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

67 Results

Guidelines and Advice

Temozolomide for the Treatment of Metastatic Melanoma

Status: Archived
ID: 8-4

Sep 2011

Guidelines and Advice

Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma

Status: Archived
ID: 8-5
Version: 2

Sep 2011

Guidelines and Advice

Ifosfamide-based Combination Chemotherapy in Advanced Soft Tissue Sarcoma

Status: Archived
ID: 11-4

Sep 2011

Guidelines and Advice

Dose-intensive Chemotherapy with Growth Factor or Autologous Bone Marrow/Stem Cell Transplant Support in Advanced or Metastatic Adult Soft Tissue Sarcoma

Status: Archived
ID: 11-5

Sep 2011

Guidelines and Advice

Sunitinib Malate for Gastrointestinal Stromal Tumour (GIST) in Imatinib Mesylate Resistant Patients

Status: Archived
ID: 11-8
Version: 2

Oct 2015

Guidelines and Advice

The Role of Trastuzumab (Herceptin) in the Treatment of Women with HER2/neu-overexpressing Metastatic Breast Cancer

Status: Archived
ID: 1-15 Version 3
Version: 3

Sep 2011

Guidelines and Advice

Implementation Strategy for Radiation Therapy Safety Straps

Status: Current
ID: GL-C50-22

Oct 2015

Guidelines and Advice

Recommendation Report: Entry and Transfer of Care Criteria for Lung Diagnostic Assessment Programs (DAPs) in Ontario

Status: Education and Information
ID: GL-C50-23-V1
Version: 2

Dec 2015

Drug Safety & Advice

Reference List for Appendix 2 - Extravasation Potential of Various Chemotherapy/Supportive Agents

Jul 2015

Statistical Reports

Cancer in the Métis People of Ontario: Risk Factors and Screening Behaviours

Jul 2015

Statistical Reports

Cancer Risk Factors in Ontario: Healthy Weights, Healthy Eating and Active Living

Mar 2015

Cancer facts

Cancers Related to Excess Body Weight on the Rise in Ontario

Dec 2015

Pages